Menu
Oslo, Norway, 9 April 2025: Scatec Invest IV, a close associate of Thor Medical board member John Andersen, has resolved a dividend of shares in Thor Medical ASA to its shareholders, including to close associates of primary insiders CFO Brede Ellingsæter and board member John Andersen in Thor Medical ASA.
Scatec Invest IV has distributed a total of 2,811,467 shares in Thor Medical ASA as dividend, based on a share price of NOK 2,25 per share.
As a result of the distribution, primary insiders have increased their controlled holding of shares in Thor Medical ASA through their close associates. B good industries AS, a close associate of Thor Medical ASA CFO Brede Ellingsæter, has received 1,081,346 shares. Scatec Innovation AS, a close associate of Thor Medical board member John Andersen, has received 417,053 shares.
Following the distribution, CFO Brede Ellingsæter controls 1,481,346 shares and holds 3,100,000 share options in Thor Medical.
Primary insider notifications pursuant to the market abuse regulation article 19 are attached.
This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 5 and the Norwegian Securities Trading Act section 5-12.
Contacts
Gisle Bjørnstad, CFO, Scatec Innovation AS, +47 95142892, gisle.bjornstad@scatec.no
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.no - https://www.thormedical.no.
